浩泽净水(02014.HK)附属获投资者注资2,500万人币
浩泽净水(02014.HK)公布,公司全资附属上海浩泽净水、间接非全资附属佛山乐普达、投资者共青城乐汇投资中心,及佛山乐普达股东彭东琨订立注资协议。投资者同意向佛山乐普达作出现金投资2,500万元人民币(下同),其中238万元用作佛山乐普达的注册资本及2,261.9万元用作佛山乐普达的资本储备。
待注资完成後,上海浩泽净水、彭东琨及投资者於佛山乐普达所拥有的股权比例将分别约为47.2%、45.4%及7.4%。
目前,佛山乐普达由上海浩泽净水及彭东琨分别持有51%及49%。待注资完成後,上海浩泽净水於佛山乐普达持有的股权将由51%摊薄至约47.2%。(ek/w)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.